These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 9117562)
41. Loss of high-affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: implications for the failure of cholinergic replacement therapies. Flynn DD; Weinstein DA; Mash DC Ann Neurol; 1991 Mar; 29(3):256-62. PubMed ID: 2042942 [TBL] [Abstract][Full Text] [Related]
42. Expression of m1 and m4 muscarinic receptor mRNA in the striatum following a selective lesion of striatonigral neurons. Harrison MB; Tissot M; Wiley RG Brain Res; 1996 Sep; 734(1-2):323-6. PubMed ID: 8896841 [TBL] [Abstract][Full Text] [Related]
43. Differential alterations in muscarinic receptor subtypes in Alzheimer's disease: implications for cholinergic-based therapies. Flynn DD; Ferrari-DiLeo G; Levey AI; Mash DC Life Sci; 1995; 56(11-12):869-76. PubMed ID: 10188787 [TBL] [Abstract][Full Text] [Related]
44. Autoradiographic comparison of [3H](-)nicotine, [3H]cytisine and [3H]epibatidine binding in relation to vesicular acetylcholine transport sites in the temporal cortex in Alzheimer's disease. Sihver W; Gillberg PG; Svensson AL; Nordberg A Neuroscience; 1999; 94(3):685-96. PubMed ID: 10579560 [TBL] [Abstract][Full Text] [Related]
45. Muscarinic activation of a voltage-dependent cation nonselective current in rat association cortex. Haj-Dahmane S; Andrade R J Neurosci; 1996 Jun; 16(12):3848-61. PubMed ID: 8656279 [TBL] [Abstract][Full Text] [Related]
46. Muscarinic receptor stimulation increases the spontaneous [3H]GABA release in the rat substantia nigra through muscarinic receptors localized on striatonigral terminals. Kayadjanian N; Gioanni H; Ménetrey A; Besson MJ Neuroscience; 1994 Dec; 63(4):989-1002. PubMed ID: 7700520 [TBL] [Abstract][Full Text] [Related]
47. Properties of cholinergic responses in neurons in the intermediate grey layer of rat superior colliculus. Sooksawate T; Isa T Eur J Neurosci; 2006 Dec; 24(11):3096-108. PubMed ID: 17156371 [TBL] [Abstract][Full Text] [Related]
48. [3H]N-methyl-carbamylcholine, a new radioligand specific for nicotinic acetylcholine receptors in brain. Boksa P; Quirion R Eur J Pharmacol; 1987 Jul; 139(3):323-33. PubMed ID: 3666008 [TBL] [Abstract][Full Text] [Related]
50. Monoclonal antibodies reveal the cellular localization and expression of cortical nicotinic and muscarinic cholinoceptors in human cerebral cortex. Schröder H Prog Histochem Cytochem; 1992; 26(1-4):266-70. PubMed ID: 1484965 [No Abstract] [Full Text] [Related]
51. Muscarinic-induced modulation of potassium conductances is unchanged in mouse hippocampal pyramidal cells that lack functional M1 receptors. Rouse ST; Hamilton SE; Potter LT; Nathanson NM; Conn PJ Neurosci Lett; 2000 Jan; 278(1-2):61-4. PubMed ID: 10643801 [TBL] [Abstract][Full Text] [Related]
52. Selective localization of striatal D1 receptors to striatonigral neurons. Harrison MB; Wiley RG; Wooten GF Brain Res; 1990 Oct; 528(2):317-22. PubMed ID: 2148707 [TBL] [Abstract][Full Text] [Related]
53. Muscarinic and nicotinic cholinergic agonists: structural analogies and discrepancies. Bikádi Z; Simonyi M Curr Med Chem; 2003 Dec; 10(23):2611-20. PubMed ID: 14529475 [TBL] [Abstract][Full Text] [Related]
54. Involvement of nicotinic and muscarinic receptors in the endogenous cholinergic modulation of the balance between excitation and inhibition in the young rat visual cortex. Lucas-Meunier E; Monier C; Amar M; Baux G; Frégnac Y; Fossier P Cereb Cortex; 2009 Oct; 19(10):2411-27. PubMed ID: 19176636 [TBL] [Abstract][Full Text] [Related]
55. Regional distribution of muscarinic and nicotinic cholinergic receptor binding activities in the human brain. Perry EK; Smith CJ; Perry RH; Whitford C; Johnson M; Birdsall NJ J Chem Neuroanat; 1989; 2(4):189-99. PubMed ID: 2597358 [TBL] [Abstract][Full Text] [Related]
56. Cholinergic stimulation enhances cytosolic calcium ion accumulation in mouse hippocampal CA1 pyramidal neurones during short action potential trains. Beier SM; Barish ME J Physiol; 2000 Jul; 526 Pt 1(Pt 1):129-42. PubMed ID: 10878106 [TBL] [Abstract][Full Text] [Related]
57. Pharmacological activity of N-methyl-carbamylcholine, a novel acetylcholine receptor agonist with selectivity for nicotinic receptors. Boksa P; Quik M; Mitchell JB; Collier B; O'Neil W; Quirion R Eur J Pharmacol; 1989 Nov; 173(1):93-108. PubMed ID: 2606158 [TBL] [Abstract][Full Text] [Related]
58. Preservation of acetylcholine muscarinic M2 receptor G-protein interactions in the neocortex of patients with Alzheimer's disease. Hérnandez-Hérnandez A; Adem A; Ravid R; Cowburn RF Neurosci Lett; 1995 Feb; 186(1):57-60. PubMed ID: 7783950 [TBL] [Abstract][Full Text] [Related]
59. AF150(S) and AF267B: M1 muscarinic agonists as innovative therapies for Alzheimer's disease. Fisher A; Brandeis R; Bar-Ner RH; Kliger-Spatz M; Natan N; Sonego H; Marcovitch I; Pittel Z J Mol Neurosci; 2002; 19(1-2):145-53. PubMed ID: 12212772 [TBL] [Abstract][Full Text] [Related]
60. Nicotine-induced switch in the nicotinic cholinergic mechanisms of facilitation of long-term potentiation induction. Yamazaki Y; Jia Y; Hamaue N; Sumikawa K Eur J Neurosci; 2005 Aug; 22(4):845-60. PubMed ID: 16115208 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]